Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical performance of a novel and rapid bioassay for detection of thyroid-stimulating immunoglobulins in Graves' orbitopathy patients: a comparison with two commonly used immunoassays.
Hötte GJ, de Bie M, de Keizer ROB, Kolijn PM, Drexhage RC, Veenbergen S, Versnel MA, van Hagen PM, Paridaens D, Dik WA. Hötte GJ, et al. Among authors: de keizer rob. Front Endocrinol (Lausanne). 2024 Sep 27;15:1469179. doi: 10.3389/fendo.2024.1469179. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39398334 Free PMC article.
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Alsoud D, Moes DJAR, Wang Z, Soenen R, Layegh Z, Barclay M, Mizuno T, Minichmayr IK, Keizer RJ, Wicha SG, Wolbink G, Lambert J, Vermeire S, de Vries A, Papamichael K, Padullés-Zamora N, Dreesen E. Alsoud D, et al. Among authors: keizer rj. Ther Drug Monit. 2024 Jun 1;46(3):291-308. doi: 10.1097/FTD.0000000000001204. Epub 2024 Apr 17. Ther Drug Monit. 2024. PMID: 38648666
Thyroid stimulating immunoglobulin concentration is associated with disease activity and predicts response to treatment with intravenous methylprednisolone in patients with Graves' orbitopathy.
Hötte GJ, Kolijn PM, de Bie M, de Keizer ROB, Medici M, van der Weerd K, van Hagen PM, Paridaens D, Dik WA. Hötte GJ, et al. Among authors: de keizer rob. Front Endocrinol (Lausanne). 2024 Mar 21;15:1340415. doi: 10.3389/fendo.2024.1340415. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38577576 Free PMC article.
231 results